Top 10 Key Players companies in Multiple sklerose by Most Patent Filings in the Switzerland in 2018 – Discovery

Free Trial

The Multiple sklerose top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filings Multiple sklerose Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	Novartis AG	Basel-Stadt, Switzerland	Dosage form,Health care,Medicine, ...[+2]	Patent: 113
2	F. Hoffmann-La Roche Ltd.	Switzerland	Medicine,Health care,Drug, ...[+2]	Patent: 78
3	Ares Trading SA	Switzerland		Patent: 16
4	Idorsia Ltd.	Basel-Landschaft, Switzerland	Medicine,Health care,Cerebral vasospasm, ...[+2]	Patent: 13
5	Idorsia Pharmaceuticals Ltd.	Switzerland	Herb,Botanical drug	Patent: 13
6	Glenmark Pharmaceuticals SA	Neuchâtel, Switzerland	Medicine	Patent: 10
7	Baxter Healthcare SA	Zürich, Switzerland	Healthcare system,Medicine	Patent: 7
8	Octapharma AG	Schwyz, Switzerland	Medicine,Health care,Collective responsibility, ...[+2]	Patent: 3
9	GeNeuro	Genève, Switzerland	Multiple sclerosis,Health care,Pharmacy and Therapeutics, ...[+2]	Patent: 3
10	GeNeuro SA	Switzerland	Chronic inflammatory demyelinating polyneuropathy,Medicine,Clinical trial, ...[+2]	Patent: 3

Page generation time: Jul 23 2025

Top 10 Key Players companies in Multiple sklerose
by Most Patent Filings in the Switzerland in 2018

Key Players

Fast-growings

Startups & Unicorns

New Entrants

2022

2021

2020

2019

2018

Global

China

Japan

India

Israel

Switzerland

United States

Germany

France

United Kingdom

Belgium

Spain

South Korea

Netherlands

Sweden

Canada

Australia

Italy

Most Patent Filings

Highest Patent Value

Most Patent Citation

Who we serve

Why Discovery

Social media

Try Discovery